Wall Street is positive on DENTSPLY SIRONA Inc (XRAY). On average, analysts give DENTSPLY SIRONA Inc a Buy rating. The average price target is $35.7, which means analysts expect the stock to increase by 13.55% over the next twelve months. That average ranking earns DENTSPLY SIRONA Inc an Analyst Rating of 26, which is better than 26% of stocks based on data compiled by InvestorsObserver.
Wall Street analysts are rating XRAY a Buy today. Find out what this means to you and get the rest of the rankings on XRAY!